EvoNext posts low 2025 cash burn as it pursues reverse takeover and eyes arbitration upside

An update from Evolva Holding ( (CH:EVE) ) is now available.

EvoNext Holdings SA has released its 2025 full-year report, showing liquidity of CHF 5.9 million, total assets of CHF 6.8 million and equity of CHF 5.9 million, with an underlying annual cash burn below CHF 0.3 million and an operating loss of CHF 0.7 million driven by transaction search costs. The board reports that several reverse takeover options were explored in 2025 without agreement, but continues disciplined M&A efforts, while an arbitration award against B&D Nutritional Ingredients assigned to EvoNext in 2026 could offer upside if collected, and the company prepares for its AGM on 20 May 2026.

An arbitration ruling in favour of Danstar Ferment AG, now assigned to EvoNext, obliges B&D Nutritional Ingredients to pay more than USD 568,000 plus interest, leading to the release of CHF 0.6 million from escrow and recognition of a receivable fully provisioned as a conservative measure. The board underscores that the platform’s value lies in its optionality as a clean listed vehicle with cash, and it remains confident of identifying an appropriate M&A transaction to drive the next phase of development, although no deal has yet been secured and collection of the arbitration award remains uncertain.

More about Evolva Holding

EvoNext Holdings SA, formerly Evolva Holding SA, is a well-capitalized shell-like Platform listed on SIX Swiss Exchange, focused on using its clean listing and cash position to pursue a reverse takeover. The company positions itself as an M&A vehicle with no latent liabilities and modest cash burn, targeting public merger opportunities rather than continuing legacy operations.

Average Trading Volume: 8,231

Technical Sentiment Signal: Sell

Current Market Cap: CHF6.88M

For detailed information about EVE stock, go to TipRanks’ Stock Analysis page.